Oral contraceptives and venous thromboembolism
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b3164 (Published 13 August 2009) Cite this as: BMJ 2009;339:b3164- Nick Dunn, senior lecturer in medical education
- 1Biomedical Sciences Building, University of Southampton Medical School, Southampton SO16 7PX
- nick.dunn{at}soton.ac.uk
More than 100 million women use the oral contraceptive pill worldwide.1 Many types of pill are available—26 types are listed in the British National Formulary—and the choice of which one to use is important to the women who use them and their doctors. Two linked studies assess the risk of venous thromboembolism in women taking the combined oral contraceptive.2 3
All oral contraceptives are effective in preventing pregnancy if they are taken correctly, so the choice of which one to use rests on the profile of side effects. Venous thromboembolism is one of the most serious side effects, and although it is rare, it can cause death (in about 1-2% of all cases of venous thromboembolism in women taking the pill).
Van Hylckama Vlieg and colleagues (doi:10.1136/bmj.b2921) present a case-control study from six anticoagulation clinics in the Netherlands, and Lidegaard …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.